Literature DB >> 10700442

Myosin heavy chain isoform expression in the failing and nonfailing human heart.

S Miyata1, W Minobe, M R Bristow, L A Leinwand.   

Abstract

In the heart, the relative proportions of the 2 forms of the motor protein myosin heavy chain (MyHC) have been shown to be affected by a wide variety of pathological and physiological stimuli. Hearts that express the faster MyHC motor protein, alpha, produce more power than those expressing the slower MyHC motor protein, beta, leading to the hypothesis that MyHC isoforms play a major role in the determination of cardiac contractility. We showed previously that a significant amount of alphaMyHC mRNA is expressed in nonfailing human ventricular myocardium and that alphaMyHC mRNA expression is decreased 15-fold in end-stage failing left ventricles. In the present study, we determined the MyHC protein isoform content of human heart samples of known MyHC mRNA composition. We demonstrate that alphaMyHC protein was easily detectable in 12 nonfailing hearts. alphaMyHC protein represented 7.2+/-3.2% of total MyHC protein (compared with approximately 35% of the MyHC mRNA), suggesting that translational regulation may be operative; in contrast, there was effectively no detectable alphaMyHC protein in the left ventricles of 10 end-stage failing human hearts.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10700442     DOI: 10.1161/01.res.86.4.386

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  192 in total

Review 1.  Sex is a potent modifier of the cardiovascular system.

Authors:  Leslie A Leinwand
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

2.  Altered in vivo left ventricular torsion and principal strains in hypothyroid rats.

Authors:  Yong Chen; Aleefia Somji; Xin Yu; Julian E Stelzer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-08-20       Impact factor: 4.733

3.  Altered left ventricular performance in aging physically active mice with an ankle sprain injury.

Authors:  Michael J Turner; Sophie Guderian; Erik A Wikstrom; Joshua R Huot; Bailey D Peck; Susan T Arthur; Joseph S Marino; Tricia Hubbard-Turner
Journal:  Age (Dordr)       Date:  2016-01-23

4.  Sildenafil reverses the hypertrophy of mice right ventricle caused by hypoxia but does not reverse the changes in the myosin heavy chain isoforms.

Authors:  Mukhallad A Aljanabi; Mahmoud A Alfaqih; Anwar Mohammad A Al-Khayat; Hameed N Bataineh
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2020-06-15

Review 5.  Myofibrillar remodeling in cardiac hypertrophy, heart failure and cardiomyopathies.

Authors:  Jarmila Machackova; Judit Barta; Naranjan S Dhalla
Journal:  Can J Cardiol       Date:  2006-09       Impact factor: 5.223

6.  Pregnancy late in rodent life has detrimental effects on the heart.

Authors:  Eunhee Chung; Kaylan M Haizlip; Leslie A Leinwand
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-05-11       Impact factor: 4.733

7.  Nitric oxide synthase-2 induction optimizes cardiac mitochondrial biogenesis after endotoxemia.

Authors:  Crystal M Reynolds; Hagir B Suliman; John W Hollingsworth; Karen E Welty-Wolf; Martha Sue Carraway; Claude A Piantadosi
Journal:  Free Radic Biol Med       Date:  2008-11-27       Impact factor: 7.376

8.  Cardiac myosin heavy chain isoform exchange alters the phenotype of cTnT-related cardiomyopathies in mouse hearts.

Authors:  Ron Rice; Pia Guinto; Candice Dowell-Martino; Huamei He; Kirsten Hoyer; Maike Krenz; Jeffrey Robbins; Joanne S Ingwall; Jil C Tardiff
Journal:  J Mol Cell Cardiol       Date:  2009-12-31       Impact factor: 5.000

9.  In vivo and in vitro cardiac responses to beta-adrenergic stimulation in volume-overload heart failure.

Authors:  Anuradha Guggilam; Kirk R Hutchinson; T Aaron West; Amy P Kelly; Maarten L Galantowicz; Amy J Davidoff; Sakthivel Sadayappan; Pamela A Lucchesi
Journal:  J Mol Cell Cardiol       Date:  2012-12-07       Impact factor: 5.000

10.  Removal of the N-terminal extension of cardiac troponin I as a functional compensation for impaired myocardial beta-adrenergic signaling.

Authors:  Han-Zhong Feng; Min Chen; Lee S Weinstein; Jian-Ping Jin
Journal:  J Biol Chem       Date:  2008-09-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.